Michael Noel Cocchi MD

Dr. Cocchi currently practices as an attending physician in the emergency department and as an intensivist in the surgical intensive care units at BIDMC. After graduating from the University of Massachusetts Medical School, he completed his residency in Emergency Medicine at the Harvard Affiliated Emergency Medicine Residency at BIDMC, followed by a two-year fellowship in Critical Care Medicine. He is board-certified in Emergency Medicine, Critical Care Medicine, and Neurocritical Care.

His research interests have primarily focused on critical care topics, in particular cardiac arrest, sepsis, and shock. He is currently the Principal Investigator of Phase II clinical trial studying the effects of esmolol in septic shock, funded by the American Heart Association. He is the course co-director of the biannual Harvard Shock Symposium and has served as an evidence reviewer for the post-cardiac arrest guidelines for the American Heart Association.

In addition to his clinical duties and research, Dr. Cocchi’s administrative responsibilities include serving as the Director of Critical Care Quality for the Silverman Institute for Health Care Quality and Safety within the Department of Health Care Quality at BIDMC. In that role, he oversees all quality assurance-related matters, as well as quality improvement endeavors, across the 9 adult ICUs at BIDMC. He also serves as an Associate Medical Director for Boston MedFlight, air and ground critical care transport service supporting the major teaching hospitals in Boston. A unifying theme of his clinical research and administrative work is improving the delivery of safe and high-quality care to critically ill patients in the pre-hospital, ED, and ICU settings, in order to achieve improved outcomes for these most vulnerable patients.